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Abstract
Background: Being homeless entails higher mortality, morbidity, and prevalence of psychiatric diseases. This leads to
more frequent and expensive use of health care services. Medical respite care enables an opportunity to recuperate
after a hospitalization and has shown a positive effect on readmissions, but little is known about the cost-effectiveness
of medical respite care for homeless people discharged from acute hospitalization. Therefore, the aim of the present
study was to investigate the cost-effectiveness of a 2-week stay in post-hospital medical respite care.
Methods: A randomized controlled trial and cost-utility analysis, from a societal perspective, was conducted between April
2014 and March 2016. Homeless people aged > 18 years with an acute admission were included from 10 different hospitals
in the Capital Region of Denmark. The intervention group (n= 53) was offered a 2-week medical respite care stay at a Red
Cross facility and the control group (n= 43) was discharged without any extra help (usual care), but with the opportunity to
seek help in shelters and from street nurses and doctors in the municipalities. The primary outcome was the difference in
health care costs 3months following inclusion in the study. Secondary outcomes were change in health-related quality of
life and health care costs 6months following inclusion in the study. Data were collected through Danish registries, financial
management systems in the municipalities and at the Red Cross, and by using the EQ-5D questionnaire.
Results: After 3 and 6months, the intervention group had €4761 (p=0.10) and €8515 (p=0.04) lower costs than the control
group, respectively. Crude costs at 3months were €8448 and €13,553 for the intervention and control group respectively. The
higher costs in the control group were mainly related to acute admissions. Both groups had minor quality-adjusted life year gains.
Conclusions: This is the first randomized controlled trial to investigate the cost-effectiveness of a 2-week medical respite care stay
for homeless people after hospitalization. The study showed that the intervention is cost-effective. Furthermore, this study illustrates
that it is possible to perform research with satisfying follow-up with a target group that is hard to reach.
Trial registration: ClinicalTrials.gov Identifier: NCT02649595.
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Background
Homelessness is increasing in high-income countries [1–3].
Homeless people generally have higher mortality and mor-
bidity, including a high prevalence of psychiatric disorders
and substance use problems [1, 4, 5]. Overall, this leads to
substantially higher use of health care services and more fre-
quent hospitalizations, resulting in higher health care costs
compared to the general population [6–8]. Over the last dec-
ade, the average number of inpatient days has decreased, and
there has been a tendency to provide more health care on an
outpatient basis [9]. This can be particularly challenging for
homeless people, as living on the street after hospitalization
is not conducive to recovery [10]. Doran et al. showed that
70.3% of all hospitalizations of homeless people result in ei-
ther readmission or an emergency department visit within
30 days after discharge, with approximately 75% of the hos-
pital readmissions occurring within the first 2 weeks after
hospital discharge [11]. Another consequence of homeless-
ness is prolongation of in-hospital stay due to postponement
of discharge [8], also termed “alternative level of care”, refer-
ring to patients who no longer need the treatment provided
in acute care hospitals [12].
A possible solution could be medical respite care,
which is described by the National Health Care for the
Homeless Council as ‘acute and post-acute care for per-
sons experiencing homelessness who are too ill or frail
to recover from a physical illness or injury on the streets
but are not ill enough to be in a hospital’ [13]. Medical
respite care has attracted increased attention [14, 15],
primarily because it has been shown to reduce future
hospital admissions, as well as length of in-hospital stay,
among homeless people discharged from an acute
hospitalization, thereby releasing beds for people in need
of acute medical care [16]. In addition, medical respite
care enables cooperation with other social and health
care services, such as primary care, social services, and
outpatient medical care [14]. Staying in respite care and
the improved opportunity to cooperate with municipal-
ities seems to have a positive impact on substance abuse
problems [15, 17]. Thus, it seems likely that medical res-
pite care for homeless people can be part of the solution
to a complex problem. However, the cost-effectiveness
of medical respite care for homeless people needs to be
investigated. In this randomized controlled trial, we in-
vestigated whether a 2-week medical respite care stay
after an acute hospitalization is a cost-effective interven-
tion for homeless people from a societal perspective.
Furthermore, we investigated whether the intervention
can improve health-related quality of life.
Methods
The study is a collaboration between Red Cross Copenhagen
and Amager and Hvidovre Hospital, a large university hos-
pital in the Danish capital region in the suburbs of
Copenhagen. The Red Cross provided the medical respite
care facilities, and Amager and Hvidovre Hospital planned
and conducted the scientific evaluation and outcome assess-
ment in relation to the present study.
Study design
The study “Bridge Copenhagen – medical respite care
for homeless people” is a pragmatic randomized con-
trolled trial including a health economic evaluation.
Setting
In Denmark, access to health care services, such as
hospitalization and general practitioners, is free of charge,
as most of the health care sector is financed by taxes. Hos-
pitals are responsible for treating diseases in the acute
phase, as well as the outpatient follow-up. The municipal-
ities are responsible for rehabilitation after hospitalization,
as well as other primary health care services, including
services aimed at homeless people after discharge from
the hospital. In Copenhagen, the health care services for
homeless people includes street clinics with doctors and
nurses, shelters, rehabilitation centers, drop-in centers,
and inpatient and outpatient therapy for use of drugs and
alcohol. The services are operated by municipalities and
non-governmental organizations (NGOs).
The hospitals in the Capital Region of Denmark have
employed nurses with specific training and experience in
working with socially marginalized people, including
homeless people and people with problematic use of al-
cohol and drugs [18]. These social nurses assist in opti-
mizing hospital treatment and care for marginalized
patients. Upon discharge, they can facilitate contact with
shelters and municipalities for further help. At the time
of this study, the social nurses were the ones referring
patients for stays in medical respite care [18].
Participants
Acutely admitted patients age ≥ 18 years who were self-
reported homeless or functionally homeless and were
going to be discharged from one of the 10 hospitals in
the Capital Region of Denmark were offered inclusion in
the study. The term ‘functionally homeless’ refers to a
person who formally has an address but cannot stay
there due to, for example, violence, threats, or poor con-
dition of the residence [19]. If participants were not able
to be alone during the night, use the stairs to the first
floor, were not self-reliant in daily activities, or were il-
legal immigrants, they were excluded due to internal
rules at the center. If the social nurses or the principal
investigator was in doubt about whether the patient ful-
filled the inclusion criteria, they would consult the head
of the medical respite care center. Questionnaires, pa-
tient information, and the consent form were available
in Danish, English, Polish, Russian, and French; patients
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who could not read these languages were not included.
There were no restrictions regarding drug and alcohol
use. Because the study was conducted as a pragmatic
randomized study in a normal clinical setting, we were
not able to produce a full flowchart of all the homeless
patients attending the hospitals during the study period.
However, we collected data 1 month in September 2015
about all patients who were in contact with the social
nurses but did not comply with inclusion criteria.
Post-hospital medical respite care intervention
In April 2014, Red Cross Copenhagen opened a medical
respite care center with four beds for homeless people
discharged after hospitalization. After 6 months, the cap-
acity expanded to eight beds. The place was led by a
paid registered nurse (RN) and primarily staffed with
volunteers. The medical respite care center offered a 2-
week stay including three meals a day, free of charge.
The patients were accommodated in double rooms with
attached bathrooms. The RN assisted with uncompli-
cated nursing tasks, such as caring for wounds, helping
with medicine, catheter care, and monitoring of blood
glucose, and helped patients with social issues, such as
housing and communicating with municipalities about
the provision of further services. The Red Cross medical
respite care center differed from the services in the mu-
nicipality in two important ways: it was free of charge,
and there were no restrictions regarding drug and alco-
hol use. The medical respite center was financed by the
government during the study period.
The control group was discharged from the hospital
with help from the social nurses, but independently had
to seek help from the described standard municipal facil-
ities, such as shelters, street nurses, and doctors.
Randomization and blinding
The randomization was conducted in blocks of four with
a 2:2 ratio and stratified for each hospital to ensure that
each hospital had a chance to refer the homeless patients
and that there was broad representation of patients from
all over the Capital Region. The randomization was per-
formed when the patient was ready for discharge. Partici-
pants were included by one of the 10 social nurses. When
a possible participant for the study was identified, the so-
cial nurse informed the patient about the medical respite
center and the study design. The patient signed an in-
formed consent form and answered the health-related
quality of life (EQ-5D-5 L) questionnaire [20]. The social
nurse called the medical respite center, where the em-
ployees drew a sealed opaque envelope that concealed the
group to which the participant was assigned. Thus, the ac-
tual draw took place in the respite center, where group as-
signment was also revealed. Afterwards, the primary
investigator double checked the randomization. The
principal investigator was the only one who knew the
randomization code and prepared the envelopes. The first
six patients included in the study were all assigned to the
intervention group without randomization to get the med-
ical respite care program up and running. Blinding of the
participants was not possible due to the nature of the
study. However, data analysis was performed blinded by a
single researcher (M.K.).
Study perspective
This study is one of a few randomized controlled studies
performed in acutely admitted homeless patients, a so-
cially stigmatized group [21]. The perspective of the eco-
nomic evaluation is societal. The preconception is that it
is challenging to perform randomized controlled trials
with follow-up in a population of homeless people [22].
Therefore, we initially designed the period of the eco-
nomic evaluation to be 3 months in an attempt to pre-
vent the study from suffering from a high drop-out rate
[22]. The societal perspective of the economic evaluation
was based on costs from the health and social care sec-
tor; however, some costs (e.g., prison) were not included.
We included all costs from the Danish health care sys-
tem, municipalities, and the medical respite care center.
The analysis will not include patients’ or families’ use of
time because homeless people often have limited or no
contact with family and peers and are primarily sup-
ported by transfer income [23, 24]. Any costs or savings
related to participants finding stable housing as a posi-
tive consequence of the medical respite care stay could
be relevant to the investigation but is beyond the scope
of this study.
Outcomes and measures
The primary outcome was a difference in health care
costs for a period of 3 months after hospital discharge.
Data on the costs of the health care services provided in
hospitals and at general practitioners were extracted
from the National Patient Register and the National
Health Insurance Service Register through Statistics
Denmark. Costs in the municipalities were collected
through databases in the municipalities in the Capital
Region of Denmark. We received information about the
type of health care service, date of accounting, and costs.
The costs of the medical respite care center were re-
trieved through Red Cross Copenhagen. Costs in Danish
kroner (DKK) were converted to Euro (€) using the ex-
change rate €1 = 7.5 DKK [25]. Data about immigrants
without a Danish social security number were retrieved
manually by their provisory social security number in
the medical journals.
Secondary outcomes were a change in health-related
quality of life (HRQoL), health care costs after a period
of 6 months, and health care costs grouped into elective
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health care costs, acute health care costs, and social
costs after a period of 6 months. The HRQoL were mea-
sured by EQ-5D-5 L at baseline, after 2 weeks, and after
3 months. The measurement at 3 months was decided
after inclusion of the first 25 participants because the 2-
week time horizon was deemed rather short and we
found it was possible to perform a satisfying follow-up
after 3 months. The EQ-5D-5 L is a generic and vali-
dated questionnaire that measures HRQoL in five di-
mensions: mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression [26]. Each question
has five possible answers: no problems, slight problems,
moderate problems, severe problems, or unable to/ex-
tremely. The answers can give a total of 3125 possible
health states that can each be converted to an index
value using the cross-walk value set [26]. The index
values are used to calculate quality-adjusted life years
(QALYs), which is the outcome presented in this study.
Compared to the EQ-5D-3 L, the EQ-5D-5 L is more
sensitive and able to detect smaller differences in inter-
ventions and treatments [20]. The QALY measurement
had the same time horizon as the cost measurements: 3,
6, and 12 months.
Follow-up was conducted mainly by the primary inves-
tigator either as personal interviews face-to-face or by
phone. Nurses and social workers in the municipalities
assisted in collecting the follow-up questionnaires based
on instructions from the primary investigator.
Participant characteristics and covariates were col-
lected from Danish registries: age, gender, having a so-
cial security number, source of income, highest
completed education, admissions 2 years prior to inclu-
sion, psychiatric diagnoses, and the Charlson Comorbid-
ity Index, indicating the burden of diseases [27]. Use of
drugs and alcohol and housing status were collected
from a database registering services provided by the so-
cial nurses, and information about what kind of help the
intervention group received at the medical respite center
was retrieved from the database of the medical respite
center.
Sample size was calculated to detect a 25% difference
in cost between the two groups. With estimated health
care costs of €13,402 in the control group, standard de-
viation of €5259, a significance level of 5%, and a power
of 80%, 96 patients were needed assuming 20% loss to
follow-up.
Assessment of costs
To investigate whether a medical respite care stay influ-
enced the participants’ use of social and health care ser-
vices, we split the costs into three categories: elective
health care costs, acute health care costs, and social
costs. Elective health care costs relate to all planned
health care services, such as visits to the general
practitioner, outpatient visits, elective hospitalization, re-
habilitation in the municipalities, and inpatient and out-
patient therapy for use of drugs and alcohol. Primary
health care tariffs were used for costing primary health
care, and a standard outpatient and bed-day tariff was
used for costing hospital services. Acute health care
costs comprise acute admissions and emergency depart-
ment visits, as well as in-hospital days after inclusion.
The latter is important because some participants
remained hospitalized after inclusion, either because
their condition deteriorated, or because they waited for
an alternative level of care. The social costs include the
social and health care services delivered in the munici-
palities, inter alia, the estimated hours of contact with
social workers, and lodging at shelters. Costs related to
the medical respite care stay were also categorized as a
social cost, but only calculated for the randomized inter-
vention group.
Hospital services and health care use in primary care
were evaluated using the National Patient Register and
National Health Insurance Service Register through Statis-
tics Denmark [28, 29]. Information on the purchase of
prescription drugs filled at pharmacies is found in the Da-
nish National Prescription Register [30]. It is customary
for the hospitals to dispense medicine to homeless people
at discharge without registering this in the electronic
health record. Furthermore, pharmaceuticals are handed
out in street clinics, where patients are sometimes treated
anonymously. Therefore, we will conduct the analysis with
and without data from the Danish National Prescription
Register. Information about health care services in the
municipalities are retrieved from both financial manage-
ment systems and manually collected information about
delivered services in street clinics. We received informa-
tion about the type of health care service, date of account-
ing, and cost of the municipal service.
The municipal costs were valued using the unit costs
given in Table 1. Health care professionals’ time was
valued based on the 2016 and 2017 mean wages for reg-
istered nurses and staff physicians (€33 and €62 per
hour, respectively) [33, 34]. Costs from the medical res-
pite care stay were obtained from the financial manage-
ment system at Red Cross Copenhagen. Costs consisted
of salaries for the daily leader and other staff, including
a consultant working in the head office at Red Cross
Copenhagen, food, washing of clothes and linen, and
cleaning and nursing requisites. Time spent by the vol-
unteers was valued by the number of volunteer hours
spent at the medical respite care center multiplied by
an estimated unit cost of €25, including perks. This es-
timate is based on the mean salary for an unskilled
worker in the welfare sector [31]. Actual days in the
medical respite care stay was registered and reported as
median (IQR).
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Costs in the primary analyses included all costs in-
curred at hospitals, general practitioners, and medical
specialists, as well as the costs of prescription drugs and
costs related to services delivered in the municipalities
and the medical respite care center. Income transfers
were excluded. Data from municipalities were double-
checked in an audit by the principal investigator and
M.K. Data from municipalities contained information on
the date of accounting, but not the date of delivery of
service; therefore, the analysis of municipal data was
only performed for the 6-month period.
Statistical analysis and cost-utility analysis
Demographic information and information on transfer
incomes and health history are presented as means,
standard deviations, and percentages. The cost-utility
analysis was performed as an intention-to-treat stochas-
tic cost-effectiveness analysis because both costs and ef-
fects were determined using data from the participants
in the study [35]. The primary analysis compared costs
during the 3months following inclusion in the study for
both groups and was adjusted for costs for the 3months
preceding inclusion.
Table 1 Cost components and unit costs
Type of resource used Unit Mean unit cost €
(IQR)
Source
Medical Respite Care
Running expensesa Per day 142 Financial management system at Red Cross
Copenhagen
Nurse (head of medical respite care) Per hour 36 Financial management system at Red Cross
Copenhagen
Volunteers Per hour 25 FOA (trade union) [31]
Employees (medical respite care) Per hour 36 Financial management system at Red Cross
Copenhagen
Health Care
Inpatient Per admission 3222 (68,964) National Patient Register, DRG-coded [29]
Outpatient Per visit 227 (3398) National Patient Register, DRG-coded [29]
Emergency department Per visit 77 (508) National Patient Register, DRG-coded [29]
Day in psychiatric ward Per admission
day
467 National Patient Register, DRG-coded [29]
Hospital days after inclusion Per day 467 National Patient Register, DRG-coded [29]
General practitioner Per hour 92 The Danish Medical Association [32]
Prescription drugs Per package 10 (409) The Danish National Prescription Registry [30]
Municipal Services
Alcohol and drug therapy (inpatient)b Per month 2400 Financial management system at municipalities
Alcohol and drug therapy (outpatient)b Per visit 467 Financial management system at municipalities
Rehabilitationb Per hour 120 Financial management system at municipalities
Drop-in center for adults with special needsb Per trajectory 347 Financial management system at municipalities
Financial management system at municipalities
Shelters for adults with social problemsb Per month 4700 Financial management system at municipalities
Nurse and careb Per hour 33 The Danish Nurses’ Association [33]
Personal assistance for adults with special
needsb
Per treatment 440 Financial management system at municipalities
Assistive devices for adults with special
needsb
Per device 186 (135) Financial management system at municipalities
Administrative costsb Per service 56 (10) Financial management system at municipalities
Personal financial supplementb Per transfer 1525 (1221) Financial management system at municipalities
Home care Per hour 25 FOA (trade union) [31]
Street nurse Per hour 33 The Danish Nurses’ Association [33]
Physician Per hour 62 The Danish Medical Association [32]
aIncludes food, cleaning, nursing articles, laundry, and perks for volunteers
bRepresentative price from the municipalities
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For the secondary analysis with a 6-month follow-up,
we adjusted for cost 6months prior to inclusion. Post-hoc,
we decided to also conduct the analyses for a 12-month
period. The baseline covered a period of 12months,
equivalent to the period following inclusion in the study.
Therefore, the cost regression was conducted as a differ-
ence in difference analysis as shown in model 1:
Ct1 ¼ αþ β1I þ β2Ct0 þ ε ð1Þ
Where I is the group assignment and C indicates costs
in the period after (t1) or before (t0) randomization.
For sensitivity analyses, we expanded the regression
analysis with other covariates, such as level of education,
Charlson Comorbidity Index, and type of homelessness
as shown in model 2:
Ct1 ¼ αþ β1I þ β2Ct0 þ β3X þ ε ð2Þ
Where X is a vector of covariates.
In addition, health care costs were divided into the
three categories (acute, elective, and social) and com-
pared in a linear regression model. HRQoL values were
used for computation of QALYs using Danish preference
weights [36, 37]. Incremental cost-effectiveness ratios
(ICERs) were computed by subtracting the QALY gain
in controls from the QALY gain in cases, obtaining the
incremental effectiveness; the incremental costs were
achieved in a similar manner. Finally, the incremental
QALY gain was divided by the incremental costs [35].
The ICER is a fraction; therefore, it is not straightfor-
ward to obtain confidence limits for the estimate. There-
fore, the costs, effects, and ICERs were bootstrapped,
drawing 10,000 samples with replacement, and the
resulting ICERs plotted in a cost-effectiveness plane. In
this exercise, whether the intervention is cost-effective is
displayed visually, and the bootstrapping results in confi-
dence interval values for the costs, effects, and ICERs
[38]. Bootstrapping was conducted on both the complete
case data set (N = 40) and a data set with imputed QALY
values in case of missing values (N = 89).
For statistical analyses, we used SAS® Enterprise Guide
version 7.1 and SAS® 9.4. The bootstrapping of ICERs
was conducted in STATA® MP 15.
Results
A total of 96 homeless people (53 intervention, 43 con-
trol) from the Capital Region of Denmark were included
in the study from April 2014 until follow-up ended in
March 2016. The first six patients were all consecutively
assigned to the intervention group, which explains the
imbalance between the intervention and control group.
The intervention group had a median length of stay of
12 (IQR 2–14) days. Four participants died during the
follow-up period, two from each group. The data
collected by social nurses in September 2015 gave infor-
mation about 286 contacts with 260 individuals. The
majority did not fulfill the inclusion criteria, as they were
not homeless (66%), not mentally able (9%), or not phys-
ically able (5%). The remaining 20% were excluded be-
cause they left against medical advice, were transferred
to another unit/hospital, required care 24 h a day, had
language barriers, or were illegal immigrants.
Participants
The 96 participants were similar in demographics and
characteristics at baseline (Table 2) and were registered in
23 municipalities across Denmark, 1 came from
Greenland, and 23 had an unknown municipality of resi-
dence, including 20 immigrants without a Danish social
security number. We received data about municipal health
care costs from nine municipalities equivalent to data
from 52 individuals. The mean age of all participants was
48 years (SD = 10), 87 were men (91%), and they were pri-
marily homeless (57%). Seventy percent of participants
had a problematic use of alcohol, whereas only 13% had
no problematic drug or alcohol use. The control group
had more admissions 2 years prior to admission, mostly in
psychiatric wards, than the intervention group (Table 2).
Health care costs
The economic evaluation of costs for 3 months showed
that the control group had on average a €4761 (p = 0.10)
higher cost than the intervention group (Table 3). The
cost difference was significant when looking at costs for
6 months, when the cost difference was €8515 (p = 0.04),
and after 12 months, when the control group had €12,
603 (p = 0.03) higher costs on average. In the sensitivity
analysis, in which we adjusted for covariates, the control
group still had higher costs than the intervention group,
€4328 (p = 0.13) after 3 months, €8161 (p = 0.05) after 6
months, and €10,687 (p = 0.06) after 12 months. Analyses
with and without data from the Danish National Pre-
scription Registry showed no differences.
Health-related quality of life and ICER
The EQ-5D-5 L questionnaire were answered by 91 par-
ticipants (95%) at baseline, 62 participants (65%) after 2
weeks, and 43 participants (61%) after 3 months. Among
the 71 participants who were offered all three question-
naires, 38 (54%) answered all three. Both groups
achieved minor QALY gains, which were slightly higher
in the intervention group but not significant (Table 4).
The ICER was negative in all models and for all
time horizons. A negative ICER is the result of either
the intervention being better and cheaper, i.e. domin-
ant, or vice versa [35]. In this case, the intervention
is dominant, or more effective and cost-saving. In the
underlying data, missing QALY values were imputed
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such that the data set used for bootstrapping con-
tained 89 individuals. Though the bootstrapping did
not render significant results, 68% of the bootstrap
replications resulted in the ICER being dominant, and
96% of replications indicated that the intervention
was cost saving. The complete case analysis showed
similar results. The plot is shown in the supplemen-
tary information (Figure S1).
Table 2 Baseline demographic and clinical characteristics by group
Characteristics Total
N = 96
Intervention group
(n = 53)
Control group
(n = 43)
Age, mean (SD) 48 (10) 48 (10) 47 (10)
Men, n (%) 87 (91) 49 (92) 38 (88)
Had social security number, n (%) 76 (79) 41 (77) 35 (81)
Drug and alcohol use, n (%) (n = 74)a
Alcohol 52 (70) 29 (67) 23 (74)
Benzodiazepines and/or hash 18 (19) 11 (21) 7 (16)
Central nervous system medication and/or opioid 17 (22) 10 (19) 7 (16)
No abuse 12 (13) 7 (13) 5 (12)
Housing status, n (%)
Homeless 55 (57) 33 (62) 22 (51)
Functional homeless 13 (14) 8 (15) 5 (12)
Otherb 12 (13) 5 (9) 7 (16)
Education, n (%)
9 years or less 34 (35) 16 (30) 18 (42)
More than 9 years 21 (22) 14 (27) 7 (16)
Not listed/Unknown 41 (43) 23 (43) 18 (42)
Social benefits 52 weeks prior to baseline, n (%)
Not eligible 23 (24) 14 (26) 9 (21)
Eligible 73 (76) 39 (74) 34 (79)
Cash assistancec
No cash assistance 31 (42) 15 (38) 16 (47)
Cash assistance 52 weeks 23 (32) 14 (36) 9 (26)
Cash assistance between 1 and 51 weeks 19 (26) 10 (26) 9 (26)
Disability pensionc
No disability pension 56 (77) 31 (79) 25 (74)
Disability pension more than 1 week 17 (23) 8 (21) 9 (26)
Other benefitsc 8 (11) 4 (10) 4 (12)
Hospital admissions 2 years prior to inclusion, n (%)
Somatic
1–3 admissions 32 (33) 18 (34) 14 (33)
> 3 admissions 41 (43) 22 (42) 19 (44)
Psychiatric
1–3 admissions 13 (14) 8 (15) 5 (12)
> 3 admissions 16 (17) 7 (13) 9 (21)
Psychiatric diagnosis, n (%) 46 (48) 24 (44) 22 (51)
Charlson Comorbidity Indexd 0,74 0,63 0,86
aInformation on drug and alcohol use based on 74 of the 96 participants
bNot registered in the Danish Population Registry, but do not see themselves as homeless
cPercentages of cash assistance, disability pension, and other benefits were calculated from the 73 persons eligible for social benefits
dCharlson Comorbidity Index score and psychiatric diagnosis was estimated using data from 2009 until inclusion
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Table 5 shows how the costs were distributed among
the categorized health services without being adjusted
for healthcare use preceding inclusion in the study. The
main difference was in the costs of acute admissions
during the first 3 months, as the control group on aver-
age used €7139 per person, compared to €3048 in the
intervention group. Costs for targeted services in the
municipalities were more than twice as high for the con-
trol group (€3573) as the intervention group (€1605).
Costs for in-hospital days after inclusion were related to
patients waiting for an “alternative level of care” and
were €814 for the control group and €255 for the inter-
vention group. Rehabilitation, drug and alcohol therapy,
and general care service expenditures were higher in the
intervention group. The supplementary material (Table
S1) shows the services provided at the Medical respite
center.
Discussion
“Bridge Copenhagen – medical respite care for home-
less people” is the first randomized study to investi-
gate the cost-effectiveness of a post-hospital medical
respite care stay for homeless people. After 3 months,
the costs in the intervention group were on average
€4761 lower per person than the costs in the control
group, but not significant. However, when we
expanded the analysis time frame to 6 and 12 months,
we found that the difference in costs between the
groups steadily increased and were significant after
both 6 and 12 months. When adjusting for length of
education, the Charlson Comorbidity Index score, and
homeless situation, the control group still had higher
costs, but the difference was significant only at 6
months.
Both groups had a small, but not significant, gain in
QALYs. There was a difference between the two groups
in QALYs, which could be explained by the difference in
the Charlson Comorbidity Index at baseline; the control
group had worse health status at randomization. The
cost-effectiveness analysis showed that the intervention
was dominant for all models and time horizons. The
cost difference was significant at 6 and 12months,
whereas the QALY difference was not significant, ren-
dering the ICER as not significant. However, the consist-
ent result that a post-hospital medical respite care stay is
less costly while not inferior to usual care indicates the
cost-effectiveness of the intervention.
There was a tendency that the intervention group
had fewer costs related to acute admissions and tar-
geted services in the municipalities and had fewer in-
hospital days after inclusion. This could be due to
health care services offered at the post-hospital
Table 3 Cost computation regression models comparing control and intervention groups (average per person)
Model 1
3 months
€
Model 1
6 months
€
Model 1
12months
€
Model 2
3 months
€
Model 2
6 months
€
Model 2
12 months
€
Constant 1721 −603 − 2865 131 − 3086 − 4806
Intervention group −4761 −8515* −12,603* −4328 −8161 −10,687
Costs before 0.15 0.25* 0.38* 0.08 0.17 0.25*
Education – – – 1318 3266 4071
Charlson Comorbidity Index – – – 1526* 2177* 5215*
Functionally homeless – – – 9139* 7826 4912
Homeless other – – – 256 − 1297 5464
Homeless missing – – – − 2787 − 4822 − 4867
R2 0.0575 0.1156 0.2038 0.1698 0.2055 0.3259
*p < 0.05
Model 1 is a difference in difference analysis and model 2 is difference in difference adjusted for level of education, Charlson Comorbidity Index and type
of homelessness
Table 4 QALY gains and ICER (average per person)
Model 1
3 months
Model 1
6 months
Model 1
12months
Model 2
3 months
Model 2
6 months
Model 2
12 months
QALYs gained in intervention group 0.0016 0.0032 0.0063 0.0016 0.0032 0.0063
QALYs gained in control group 0.0007 0.0014 0.0027 0.0007 0.0014 0.0027
ICER Dominant Dominant Dominant Dominant Dominant Dominant
Model 1 is a difference in difference analysis and model 2 is difference in difference adjusted for level of education, Charlson Comorbidity Index and type
of homelessness
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medical respite care center enhancing the possibility of full
recovery. At the same time, the intervention group had
higher costs for general care services, rehabilitation, and
treatment of substance abuse problems. One of the key re-
sults of the qualitative study by Pedersen et al., who stud-
ied the same respite care center, was that a post-hospital
medical respite care stay allowed time for reflection on,
for example, addiction problems [17]. It appears that some
of the homeless people attended drug or alcohol therapy
after the respite care stay. Taken together, it seems that a
post-hospital medical respite care stay can reduce costs
and acute admissions and increase the number of persons
receiving drug and alcohol abuse treatment.
The reduced use of health care services after a respite
care stay is supported by previous studies [39–41]. Ker-
tesz et al. found that being discharged to a homeless res-
pite care program reduced the odds of being readmitted
50% following 3months of inclusion, but the interven-
tion was not cost-effective compared to discharging the
homeless people to the streets and shelters. However,
the intervention described in that study provided 24-h a
day care with highly specialized interdisciplinary teams,
allowing for more complex patient care [39]. Buchanon
et al. reported that respite care for homeless people re-
duced costs because it reduced inpatient days [40]. Not-
ably, the costs for medical respite care in Buchanan
et al.’s study were half that of our intervention, and the
cost for a day in the hospital was roughly estimated as
being 3-times as expensive as in the present study.
Furthermore, the average length of the respite care stay
was 42 days [40]. Our eligibility criteria and the fact that
most participants used alcohol may reflect that the par-
ticipants in our study were a select group that demanded
less intensive care. These important differences give rise
to further considerations about which services should be
provided at a post-hospital medical respite care center
and when the marginal effect of one additional day ap-
proaches zero. In comparison with other interventions
such as housing first we see similar results regarding
hospital use [21], which underline the importance of
temporary or stable housing as our study reports that
23% of the intervention group obtained temporary hous-
ing in continuation of the medical respite care stay.
This study has several limitations. First, it is unclear
whether it is realistic to expect any changes in HRQoL
in such a short time period as 3 months. Second, our re-
sults should be viewed as conservative estimates because
Copenhagen offers many targeted services for homeless
people, which together improve the chances of full re-
covery regardless of post-hospital medical respite care.
Third, we did not evaluate whether the intervention
entailed some patients receiving treatment faster because
our target group could be discharged faster to an alter-
native level of care. Therefore, the full effect of medical
respite care could be even more pervasive. Lastly, data
from immigrants could be underreported because they
do not occur in Danish registers. As the control group
had a higher percentage of immigrants, the missing
Table 5 Elective, acute, and social costs at 3 and 6 months (€, crude average per person)
3 months 6 months
Intervention
€
Control
€
P-value Intervention
€
Control
€
P-value
Elective health costs
General practitioner 40 36 0.849 92 62 0.3943
Outpatient visitsa 623 708 0.794 798 1135 0.4079
Elective hospitalization 419 768 0.514 568 909 0.545
Rehabilitation – – – 1047 0 0.2945
Alcohol/drug abuse treatment – – – 898 177 .3888
Acute health care costs
Acute admission 3048 7139 0.0746 4819 12,158 0.0487
Emergency department visit 164 256 0.356 307 431 0.447
In-hospital days after inclusion 255 814 0.0901 – – –
Social costs
General care services 938 150 0.3429 1047 153 0.2945
Targeted care services 1605 3573 0.1598 2879 5328 0.2137
Medical respite care 1260 0 – 1260 0 –
Delivery of prescription drugs 96 109 0.82 164 183 0.82
Crude total 8448 13,553 0,07 13,045 20,536 0,1
aSomatic and psychiatric out-patient visit
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data may have resulted in an underestimation of the
costs in the control group. We had no information on
the length of homelessness prior to the medical respite
care stay. In future studies with more participants, it
would be relevant to include information on length of
homelessness in the analysis. Lastly, the municipal costs
are based on imprecise estimates and the accounting
method varied between municipalities. However, be-
cause of the randomization, we expect that the lack of
precision of these estimates impacts both groups simi-
larly and, therefore, should not influence the economic
evaluation.
Our study has several strengths. First, it was per-
formed as a randomized controlled trial, which is the
gold standard in medical research for investigating the
effect of an intervention but a rarely used design to
evaluate interventions for homeless people. Second, it
was performed in a “real-world” setting, where the inter-
vention was delivered by an NGO, rendering it
generalizable and can be transferred to many parts of
the world, because the results do not rely on a welfare
system like the one we have in Denmark. Third, using
Danish registries, it is possible to estimate differences in
health care costs across different sectors and services.
This allowed us to investigate whether a post-hospital
medical respite care stay is cost-effective at a societal
level. Lastly, the response rate for HRQoL was surpris-
ingly high in this population compared to other studies;
Hewet et al. were able to get in contact with approxi-
mately 25% of the homeless people for a 6-week follow-
up [22]. The participants we failed to contact were pri-
marily from the intervention group, which means our ef-
fect results could be underestimated. It is possible that
the use of health care services is reflected in the HRQoL;
therefore, future studies could expand the follow-up
time to investigate whether HRQoL increases as the
health care costs decrease. This study demonstrated that
it is possible to perform a pragmatic randomized con-
trolled trial with a low attrition rate in this socially stig-
matized population, even though it is not a tradition in
the social area. This leads to new opportunities for creat-
ing evidence-based interventions in an area that is driven
mainly by experience.
Conclusions
This study shows that post-hospital medical respite care
for homeless people in a Danish setting leads to signifi-
cant improvements in cost-effectiveness after 6 and 12
months. The differences in health care costs after 3
months follow-up also suggested cost-effectiveness, bud
did not reach statistical significance. HRQoL showed
small improvements in both groups and were highest in
the intervention group, though not significant.
This study informs policy makers and health profes-
sionals who work with homeless people and strongly
suggests that post-hospital medical respite care should
be implemented in similar health care settings.
Future studies need to address the heterogeneity of the
homeless population by either including a larger popula-
tion or focusing on certain characteristics. Furthermore,
future studies should investigate the potential benefit if
street nurses and doctors can refer homeless people dir-
ectly from the street to medical respite care, and thereby
preventing hospital admissions.
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